M. Rey

1.6k total citations
44 papers, 1.2k citations indexed

About

M. Rey is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, M. Rey has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 14 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in M. Rey's work include Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurological diseases and metabolism (7 papers). M. Rey is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Neurological diseases and metabolism (7 papers). M. Rey collaborates with scholars based in Spain, France and Switzerland. M. Rey's co-authors include Isidró Ferrer, Berta Puig, Teresa Ribalta, Adriana Cardozo, Rosa Blanco, Margarita Carmona, Mario Ezquerra, Eduardo Tolosa, Carles Gaig and E. Goutan and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

M. Rey

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Rey Spain 19 497 436 421 260 223 44 1.2k
Amanda McRae Sweden 20 326 0.7× 301 0.7× 290 0.7× 295 1.1× 397 1.8× 51 1.5k
Tomasz Brudek Denmark 21 478 1.0× 626 1.4× 266 0.6× 327 1.3× 317 1.4× 47 1.5k
Bernard Sablonnière France 24 813 1.6× 404 0.9× 298 0.7× 490 1.9× 164 0.7× 65 1.6k
Dan Sunnemark Sweden 20 400 0.8× 145 0.3× 408 1.0× 159 0.6× 310 1.4× 31 1.3k
Michael Mayne Canada 22 546 1.1× 184 0.4× 371 0.9× 357 1.4× 325 1.5× 32 1.8k
K. Jendroska Germany 14 688 1.4× 165 0.4× 325 0.8× 154 0.6× 545 2.4× 22 1.2k
Meng-Liang Zhao United States 15 389 0.8× 181 0.4× 261 0.6× 155 0.6× 540 2.4× 17 1.4k
A. E. G. Tannenberg Australia 17 365 0.7× 152 0.3× 176 0.4× 286 1.1× 137 0.6× 33 1.1k
M Wender Poland 15 300 0.6× 195 0.4× 243 0.6× 79 0.3× 104 0.5× 195 1.1k
Raghava Potula United States 21 362 0.7× 255 0.6× 119 0.3× 205 0.8× 587 2.6× 47 1.7k

Countries citing papers authored by M. Rey

Since Specialization
Citations

This map shows the geographic impact of M. Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rey more than expected).

Fields of papers citing papers by M. Rey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rey. The network helps show where M. Rey may publish in the future.

Co-authorship network of co-authors of M. Rey

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rey. A scholar is included among the top collaborators of M. Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rey. M. Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miniarikova, Jana, Raygene Martier, Cynthia Brouwers, et al.. (2017). AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease. Gene Therapy. 24(10). 630–639. 80 indexed citations
2.
Mérienne, Nicolas, et al.. (2015). Gene transfer engineering for astrocyte-specific silencing in the CNS. Gene Therapy. 22(10). 830–839. 24 indexed citations
3.
Grau‐Rivera, Oriol, Ellen Gelpí, M. Rey, et al.. (2013). Prominent psychiatric symptoms in patients with Parkinson’s disease and concomitant argyrophilic grain disease. Journal of Neurology. 260(12). 3002–3009. 18 indexed citations
4.
Lladó, Albert, Raquel Sánchez‐Valle, M. Rey, et al.. (2010). New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease. SHILAP Revista de lepidopterología. 25(1). 13–16. 7 indexed citations
5.
Lladó, Albert, Raquel Sánchez‐Valle, M. Rey, et al.. (2010). Nueva mutación en el gen PSEN1 (E120G) asociada a enfermedad de Alzheimer de inicio precoz. Neurología. 25(1). 13–16. 7 indexed citations
6.
Gaig, Carles, A. Iranzo, E. Tolosa, et al.. (2008). Pathological description of a non-motor variant of multiple system atrophy. Journal of Neurology Neurosurgery & Psychiatry. 79(12). 1399–1400. 36 indexed citations
8.
Sánchez‐Valle, Raquel, Albert Lladó, Mario Ezquerra, et al.. (2007). A novel mutation in the PSEN1 gene (L286P) associated with familial early‐onset dementia of Alzheimer type and lobar haematomas. European Journal of Neurology. 14(12). 1409–1412. 24 indexed citations
9.
Gaig, Carles, Marı́a José Martı́, Mario Ezquerra, et al.. (2007). G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. Journal of Neurology Neurosurgery & Psychiatry. 78(6). 626–628. 81 indexed citations
10.
Muntané, Gerard, Esther Dalfó, M. Rey, et al.. (2006). Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. Journal of Neurochemistry. 99(1). 177–185. 48 indexed citations
11.
Armstrong, Judith, Merçé Boada, M. Rey, Noemí Vidal, & Isidró Ferrer. (2004). Familial Alzheimer disease associated with A713T mutation in APP. Neuroscience Letters. 370(2-3). 241–243. 25 indexed citations
12.
Ferrer, Isidró, Merçé Boada, M. Rey, et al.. (2003). Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathologica. 106(5). 419–435. 57 indexed citations
13.
Ferrer, Isidró, Marta Barrachina, Markus Tolnay, et al.. (2003). Phosphorylated Protein Kinases Associated with Neuronal and Glial Tau Deposits in Argyrophilic Grain Disease. Brain Pathology. 13(1). 62–78. 51 indexed citations
14.
Ferrer, Isidró, Pau Pástor, M. Rey, et al.. (2003). Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathology and Applied Neurobiology. 29(1). 23–34. 36 indexed citations
15.
Rey, M., et al.. (2002). Aggressive Psammomatoid Ossifying Fibroma. Annals of Otology Rhinology & Laryngology. 111(5). 466–468. 11 indexed citations
16.
Ferrer, Isidró, Rosa Blanco, Margarita Carmona, et al.. (2001). Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathologica. 101(1). 49–56. 79 indexed citations
18.
Bombí, Josep Antoni, Llúcia Alós, M. Rey, et al.. (1996). Myoepithelial Carcinoma Arising in a Benign Myoepithelioma: Immunohistochemical, Ultrastructural, and Flow-Cytometrical Study. Ultrastructural Pathology. 20(2). 145–154. 19 indexed citations
19.
Varaine, Francis, et al.. (1991). Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. The Lancet. 338(8771). 862–866. 54 indexed citations
20.
Beytout, J., J. Chazal, Marie Chanal, & M. Rey. (1983). A propos de cinq cas de méningites à bacille pyocyanique. Médecine et Maladies Infectieuses. 13(10). 553–558.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026